Canine Arthritis Treatment Market: Asia Pacific Excluding Japan to Register the Fastest Growth During the Forecast Period: Global Industry Analysis (2013 - 2017) and Opportunity Assessment (2018 - 2028)
- REP-GB-3552
- 2018-07-26
- Category: Healthcare, Pharmaceuticals and Medical devices
- 260 Pages
- Format:
Canine arthritis is a degenerative condition that results in inflammation of one or more joints and progresses over time if left untreated. The most commonly affected joints include the knee, elbow, shoulder, hip and spinal column. There are various causes of arthritis in dogs such as traumatic injuries, obesity, failure of proper bone development and many others. There are several types of canine arthritis but the most common is osteoarthritis. It affects 1 in 5 adult dogs. The prevalence of osteoarthritis increases with the age of canines. Its a chronic disease characterized by the loss of cartilage. It also includes other abnormalities such as osteophytosis in response to inflammation and pain.
The canine arthritis treatment types include non-steroidal anti-inflammatory medications (NSAIDs), opioids and stem cell Canine Arthritis Treatment. Non-steroidal anti-inflammatory Canine Arthritis Treatment are used to control pain and inflammation associated with arthritis. They are most commonly used canine arthritis treatment drugs. NSAIDs are used to treat mild to moderate pain by reducing the production of prostaglandins, which is involved with inflammation and discomfort. Several non-steroidal anti-inflammatory medications approved for canine arthritis treatment are Ketaprofen, Carprofen, Deracoxib, and Rimadyl, among others. Opioids are another class of pain relief medication for canine arthritis treatment, which includes Tramadol, Tapentadol, and buprenorphine, among others. Opioids work by acting through the central opioid receptors. They are used to treat moderate to severe as well as chronic pain associated with arthritis. The stem cell therapy is a new treatment option for canine arthritis treatment. The stem cell Canine Arthritis Treatment is usually performed as canine arthritis treatment using either autologous stem cells or allogeneic stem cells Canine Arthritis Treatment. In the stem cell canine arthritis treatment, the adult stem cells are harvested from canine’s fat tissues and injected into the affected joints. The stem cell Canine Arthritis Treatment has improved the quality of life of canines by reducing pain and increasing mobility and has shown 85% success rate within 5 months of canine arthritis treatment.
In terms of revenue, the global canine arthritis treatment market is projected to expand at a CAGR of 4.4% during the forecast period and is expected to be valued at US$ 3,051.8 Mn by the end of 2028. The Asia region is expected to witness siginificant growth in Canine Arthritis Treatment market.
The global canine arthritis treatment market is segmented into seven major regions: North America, Latin America, Europe, Asia Pacific (Asia-Pacific excluding Japan), Japan and Middle East & Africa (MEA). In terms of value, North America Canine Arthritis Treatment is expected to be the dominant regional market in canine arthritis treatment by 2018 end and is expected to expand with lucrative CAGR over the forecast period. Europe and Asia Pacific excluding Japan are expected to be the fast-growing markets in terms of revenue growth in the global canine arthritis treatment market, registering healthy CAGRs over the forecast period.
In North America, the U.S. is the dominant market for canine arthritis treatment due to increased consumer spending on pets. Over the past few decades, it has been noted that the U.S. vet care spending has almost doubled owing to increase in awareness regarding the diseases in animals and accessibility of treatment and diagnostic methods for various chronic diseases. Increasing vet care spending is expected to directly impact the need for better treatment therapies and drugs, which in turn creates high growth opportunities for players operating in the canine arthritis treatment market over the forecast period. As per the American Pet Products Association, about US$ 7.4 Bn was spent on vet care in canines in 2017 in the U.S. According to the APPA (American Pet Products Association), in 2017, the pet population in the U.S. grew to 393.3 million, accounting for 89.7 million dogs.
The second dominant market in canine arthritis treatment is Germany owing to the rise in prevalence of chronic diseases in animals, particularly dogs. It has been found that with growing age of pets, the prevalence of diseases such as allergies, lower appetite, reduced energy, arthritis, lameness, dysplasia and behavioural anxieties increases, especially in dogs and cats. This growth in terms of pet adoption in European countries and increasing number of pets suffering from arthritis is likely to boost the growth of canine arthritis treatment in Europe. This has been driving the demand for innovative therapies and drugs in Canine Arthritis Treatment, such as stem cell Canine Arthritis Treatment and arthritis drugs – NSAIDs and opioids. Canine arthritis treatment/drugs in Germany have taken initiatives to incentivize innovation in the field of veterinary treatment in order to address the urgent need of better veterinary care and to combat rapid growing prevalence of animal diseases. Additionally, increasing expenditure on vet care in high economic European countries such as Germany, France and the U.K. also boosts the growth of the market for canine arthritis treatment. As per the American Pet Products Association, about US$ 6.1 Bn was spent on vet care in 2017 in Europe.
Increasing pet adoption in China and India is expected to drive the growth of the canine arthritis treatment market in Asia-Pacific. In Japan and the Middle East and Africa, the population of dogs is decreasing due to poor vet care facilities, which is expected to hamper the growth of canine arthritis treatment market to some extent.
Future Market Insights (FMI) offers a 10-year forecast on the global canine arthritis treatment market. The primary objective of the report is to offer updates and information related to market opportunities in the canine arthritis treatment market.
Report Description
In terms of revenue, the global canine arthritis treatment market is expected to register a CAGR of 4.4% during the forecast period, 2018–2028. The primary objective of the report is to offer insights on the market dynamics that can influence the growth of the global canine arthritis treatment market over the forecast period. Insights on key trends, drivers, restraints, value forecasts and opportunities for companies operating in the global canine arthritis treatment market are presented in the report.
The global market for canine arthritis treatment is expected to witness high growth rate in terms of value in high economic countries due to fast FDA approvals for novel and innovative canine arthritis treatment drugs coupled with growing adoption of stem therapy to treat arthritis. Additionally, huge investments in the research and development sector for the development of advanced stem cell therapy and drugs for arthritis in countries such as the U.S., Germany, France and U.K. is expected to create numerous opportunities for the manufacturers of canine arthritis treatment products. Manufacturers are focusing on the production of high-grade drugs with less side effects due to its high demand from end users.
The report includes canine arthritis treatment drugs such as non-steroidal anti-inflammatory medications (NSAIDs) and opioids. Also, the stem cell therapy is taken into account along with drugs to calculate revenue generation in the canine arthritis treatment market.
However, the report does not include revenue generated by the sale of other medical products such as prosthetics and medical devices. Currency fluctuations and inflation are not considered while calculating the revenue of the canine arthritis treatment market
Revenue from the canine arthritis treatment market in North America is expected to expand at the relatively higher CAGR due to growing adoption of drugs and therapies and increased consumer spending on veterinary care. To understand and assess the opportunities in this market, the report offers the market forecast on the basis of segment type classified into the treatment type, route of administration, end users and regions. The report provides analysis of the global canine arthritis treatment market in terms of market value (US$ Mn).
The global canine arthritis treatment market is segmented on the basis of treatment type into:
- Non-steroidal anti-inflammatory drugs
- Opioids
- Stem Cell Therapy
The report begins with the market definition of canine arthritis treatment, followed by definitions of the different treatment types. The market dynamics section includes FMI’s analysis on key trends, drivers, restraints, opportunities and macro-economic factors influencing the growth of the global canine arthritis treatment market.
The report analyses the canine arthritis treatment market on the basis of the route of administration and end users and presents forecast in terms of value for the next 10 years. On the basis of route of administration, the global canine arthritis treatment market is segmented into:
-
Oral
-
Injectable
On the basis of the end users, the global canine arthritis treatment market is segmented into:
-
Veterinary Hospitals and Clinics
-
Retail Pharmacies
-
Drug Stores
-
E-commerce
Next, the report analyses the market on the basis of regions and presents forecast in terms of value for the next 10 years. On the basis of region, the global canine arthritis treatment market is segmented into:
-
North America
-
U.S.
-
Canada
-
-
Latin America
-
Brazil
-
Mexico
-
Rest of Latin America
-
-
Europe
-
Germany
-
France
-
U.K.
-
Italy
-
Spain
-
Russia
-
Rest of Europe
-
-
Asia Pacific
-
India
-
China
-
Australia & New Zealand
-
ASEAN
-
Rest of APEJ
-
-
Japan
-
Middle East & Africa (MEA)
-
GCC Countries
-
South Africa
-
Rest of MEA
-
In addition, we have considered Year-on-Year (Y-o-Y) growth to understand the predictability of the market and identify growth opportunities for companies operating in the global canine arthritis treatment market.
Another key feature of this report is the analysis of key segments in terms of absolute dollar opportunity. This is usually overlooked while forecasting the market. However, absolute dollar opportunity is critical for assessing the level of opportunity that a provider can look to achieve, as well as to identify potential resources from a sales and delivery perspective for services offered by the canine arthritis treatment market. To understand the key segments in terms of their growth and performance in the global canine arthritis treatment market, Future Market Insights has developed a market attractiveness index. The resulting index will help identify the existing market opportunities in canine arthritis treatment market.
In the final section of the report, a ‘competitive landscape’ has been included to provide a dashboard view of the key companies operating in the global canine arthritis treatment market. This section is primarily designed to provide clients with an objective and detailed comparative assessment of the key providers specific to a market segment in the canine arthritis treatment market. However, this section also includes market strategies and SWOT analysis of the key players operating in the global canine arthritis treatment market.
Detailed profiles of canine arthritis treatment drug manufacturers are also included in the scope of the report to evaluate their long- and short-term strategies. Examples of some of the key players operating in the canine arthritis treatment market are Elanco (Eli Lilly and Company), Boehringer Ingelheim, Zoetis Inc., Vetoquinol S.A., Bayer AG, Aratana Therapeutics Inc., Norbrook Laboratories Limited, VetStem Biopharma, and Dechra Pharmaceuticals Plc, among others.
Canine Arthritis Market Reports - Table of Contents
1. Executive Summary
1.1. Market Overview
1.2. Market Analysis
1.3. FMI Analysis and Recommendations
1.4. Wheel of Fortune
2. Market Introduction
2.1. Market Taxonomy
2.2. Market Definition
2.3. Company Description and Canine Arthritis Treatment Market Research Coverage
3. Canine Arthritis Treatment Market Opportunity Analysis
3.1. Macro-Economic Factors
3.2. Opportunity Analysis
4. Market Background
4.1. Technology Evolution
4.2. List of Growth Hacking Manufacturers
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Trends
4.4. Regulatory Scenario
5. Global Economic Outlook
5.1. Canine Arthritis Treatment Market Outlook
6. Key Inclusions
6.1. Canine Arthritis Treatment Market Analysis
6.2. Canine Osteoarthritis Treatment Scenario
7. North America Canine Arthritis Treatment Market Analysis 2013–2017 and Forecast 2018–2028
7.1. Introduction
7.2. Historical Market Size (US$ Mn) Analysis By Country, 2013-2017
7.2.1. U.S.
7.2.2. Canada
7.3. Market Size (US$ Mn) Forecast By Country, 2018-2028
7.4. Historical Market Size (US$ Mn) Trend Analysis By Treatment Type, 2013-2017
7.4.1. Non-steroidal anti-inflammatory medications (NSAIDs)
7.4.2. Opioids
7.4.3. Stem Cell Therapy
7.4.3.1. Allogeneic Stem Cell
7.4.3.2. Autologous Stem Cell
7.5. Market Size (US$ Mn) Forecast By Treatment Type, 2018-2028
7.6. Historical Market Size (US$ Mn) Trend Analysis By Route of Administration, 2013-2017
7.6.1. Oral
7.6.2. Injectable
7.7. Market Size (US$ Mn) Forecast By Route of Administration, 2018-2028
7.8. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013-2017
7.8.1. Veterinary Hospitals & Clinics
7.8.2. Retail Pharmacies
7.8.3. Drug Stores
7.8.4. E-commerce
7.9. Market Size (US$ Mn) Forecast By End User, 2018-2028
7.10.Market Attractiveness Analysis
7.10.1. By Country
7.10.2. By Treatment Type
7.10.3. By Route of Administration
7.10.4. By End User
7.11.Drivers and Restraints: Impact Analysis
7.12.Key Market Participants – Intensity Mapping
8. Latin America Canine Arthritis Treatment Market Analysis 2013–2017 and Forecast 2018–2028
8.1. Introduction
8.2. Historical Market Size (US$ Mn) Analysis By Country, 2013-2017
8.2.1. Brazil
8.2.2. Mexico
8.2.3. Rest of Latin America
8.3. Market Size (US$ Mn) Forecast By Country, 2018-2028
8.4. Historical Market Size (US$ Mn) Trend Analysis By Treatment Type, 2013-2017
8.4.1. Non-steroidal anti-inflammatory medications (NSAIDs)
8.4.2. Opioids
8.4.3. Stem Cell Therapy
8.4.3.1. Allogeneic Stem Cell
8.4.3.2. Autologous Stem Cell
8.5. Market Size (US$ Mn) Forecast By Treatment Type, 2018-2028
8.6. Historical Market Size (US$ Mn) Trend Analysis By Route of Administration, 2013-2017
8.6.1. Oral
8.6.2. Injectable
8.7. Market Size (US$ Mn) Forecast By Route of Administration, 2018-2028
8.8. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013-2017
8.8.1. Veterinary Hospitals & Clinics
8.8.2. Retail Pharmacies
8.8.3. Drug Stores
8.8.4. E-commerce
8.9. Market Size (US$ Mn) Forecast By End User, 2018-2028
8.10.Market Attractiveness Analysis
8.10.1. By Country
8.10.2. By Treatment Type
8.10.3. By Route of Administration
8.10.4. By End User
8.11.Drivers and Restraints: Impact Analysis
8.12. Key Market Participants – Intensity Mapping
9. Europe Canine Arthritis Treatment Market Analysis 2013–2017 and Forecast 2018–2028
9.1. Introduction
9.2. Historical Market Size (US$ Mn) Analysis By Country, 2013-2017
9.2.1. Germany
9.2.2. U.K
9.2.3. France
9.2.4. Italy
9.2.5. Spain
9.2.6. Russia
9.2.7. Rest of Western Europe
9.3. Market Size (US$ Mn) Forecast By Country, 2018-2028
9.4. Historical Market Size (US$ Mn) Trend Analysis By Treatment Type, 2013-2017
9.4.1. Non-steroidal anti-inflammatory medications (NSAIDs)
9.4.2. Opioids
9.4.3. Stem Cell Therapy
9.4.3.1. Allogeneic Stem Cell
9.4.3.2. Autologous Stem Cell
9.5. Market Size (US$ Mn) Forecast By Treatment Type, 2018-2028
9.6. Historical Market Size (US$ Mn) Trend Analysis By Route of Administration, 2013-2017
9.6.1. Oral
9.6.2. Injectable
9.7. Market Size (US$ Mn) Forecast By Route of Administration, 2018-2028
9.8. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013-2017
9.8.1. Veterinary Hospitals & Clinics
9.8.2. Retail Pharmacies
9.8.3. Drug Stores
9.8.4. E-commerce
9.9. Market Size (US$ Mn) Forecast By End User, 2018-2028
9.10.Market Attractiveness Analysis
9.10.1. By Country
9.10.2. By Treatment Type
9.10.3. By Route of Administration
9.10.4. By End User
9.11.Drivers and Restraints: Impact Analysis
9.12.Key Market Participants – Intensity Mapping
10. Asia Pacific Excluding Japan (APEJ) Canine Arthritis Treatment Market Analysis 2013–2017 and Forecast 2018–2028
10.1.Introduction
10.2. Historical Market Size (US$ Mn) Analysis By Country, 2013-2017
10.2.1. China
10.2.2. India
10.2.3. Australia and New Zealand
10.2.4. ASEAN
10.2.5. Rest of APEJ
10.3.Market Size (US$ Mn) Forecast By Country, 2018-2028
10.4.Historical Market Size (US$ Mn) Trend Analysis By Treatment Type, 2013-2017
10.4.1. Non-steroidal anti-inflammatory medications (NSAIDs)
10.4.2. Opioids
10.4.3. Stem Cell Therapy
10.4.3.1. Allogeneic Stem Cell
10.4.3.2. Autologous Stem Cell
10.5.Market Size (US$ Mn) Forecast By Treatment Type, 2018-2028
10.6.Historical Market Size (US$ Mn) Trend Analysis By Route of Administration, 2013-2017
10.6.1. Oral
10.6.2. Injectable
10.7.Market Size (US$ Mn) Forecast By Route of Administration, 2018-2028
10.8.Historical Market Size (US$ Mn) Trend Analysis By End User, 2013-2017
10.8.1. Veterinary Hospitals & Clinics
10.8.2. Retail Pharmacies
10.8.3. Drug Stores
10.8.4. E-commerce
10.9.Market Size (US$ Mn) Forecast By End User, 2018-2028
10.10. Market Attractiveness Analysis
10.10.1. By Country
10.10.2. By Treatment Type
10.10.3. By Route of Administration
10.10.4. By End User
10.11. Drivers and Restraints: Impact Analysis
10.12. Key Market Participants – Intensity Mapping
11. Japan Canine Arthritis Treatment Market Analysis 2013–2017 and Forecast 2018–2028
11.1.Introduction
11.2.Historical Market Size (US$ Mn) Trend Analysis By Treatment Type, 2013-2017
11.2.1. Non-steroidal anti-inflammatory medications (NSAIDs)
11.2.2. Opioids
11.2.3. Stem Cell Therapy
11.2.3.1. Allogeneic Stem Cell
11.2.3.2. Autologous Stem Cell
11.3.Market Size (US$ Mn) Forecast By Treatment Type, 2018-2028
11.4.Historical Market Size (US$ Mn) Trend Analysis By Route of Administration, 2013-2017
11.4.1. Oral
11.4.2. Injectable
11.5.Market Size (US$ Mn) Forecast By Route of Administration, 2018-2028
11.6.Historical Market Size (US$ Mn) Trend Analysis By End User, 2013-2017
11.6.1. Veterinary Hospitals & Clinics
11.6.2. Retail Pharmacies
11.6.3. Drug Stores
11.6.4. E-commerce
11.7.Market Size (US$ Mn) Forecast By End User, 2018-2028
11.8.Market Attractiveness Analysis
11.8.1. By Treatment Type
11.8.2. By Route of Administration
11.8.3. By End User
11.9.Drivers and Restraints: Impact Analysis
11.10. Key Market Participants – Intensity Mapping
12. Middle East and Africa Canine Arthritis Treatment Market Analysis 2013–2017 and Forecast 2018–2028
12.1.Introduction
12.2. Historical Market Size (US$ Mn) Analysis By Country, 2013-2017
12.2.1. GCC Countries
12.2.2. South Africa
12.2.3. Rest of Middle East and Africa
12.3.Market Size (US$ Mn) Forecast By Country, 2018-2028
12.4.Historical Market Size (US$ Mn) Trend Analysis By Treatment Type, 2013-2017
12.4.1. Non-steroidal anti-inflammatory medications (NSAIDs)
12.4.2. Opioids
12.4.3. Stem Cell Therapy
12.4.3.1. Allogeneic Stem Cell
12.4.3.2. Autologous Stem Cell
12.5.Market Size (US$ Mn) Forecast By Treatment Type, 2018-2028
12.6.Historical Market Size (US$ Mn) Trend Analysis By Route of Administration, 2013-2017
12.6.1. Oral
12.6.2. Injectable
12.7.Market Size (US$ Mn) Forecast By Route of Administration, 2018-2028
12.8.Historical Market Size (US$ Mn) Trend Analysis By End User, 2013-2017
12.8.1. Veterinary Hospitals & Clinics
12.8.2. Retail Pharmacies
12.8.3. Drug Stores
12.8.4. E-commerce
12.9.Market Size (US$ Mn) Forecast By End User, 2018-2028
12.10. Market Attractiveness Analysis
12.10.1. By Country
12.10.2. By Treatment Type
12.10.3. By Route of Administration
12.10.4. By End User
12.11. Drivers and Restraints: Impact Analysis
12.12. Key Market Participants – Intensity Mapping
13. Forecast Factors: Relevance and Impact
14. Forecast Assumptions
15. Competition Analysis
15.1.Competition Dashboard
15.2.Company Deep Dive
15.2.1. Elanco (Eli Lily and Company)
15.2.1.1. Overview
15.2.1.2. Product and Application Portfolio
15.2.1.3. Production Footprint
15.2.1.4. Sales Footprint
15.2.1.5. Channel Footprint
15.2.1.6. Strategy
15.2.1.6.1. Marketing Strategy
15.2.1.6.2. Product Strategy
15.2.1.6.3. Channel Strategy
15.2.2. Ceva Santé Animale
15.2.2.1. Overview
15.2.2.2. Product and Application Portfolio
15.2.2.3. Production Footprint
15.2.2.4. Sales Footprint
15.2.2.5. Channel Footprint
15.2.2.6. Strategy
15.2.2.6.1. Marketing Strategy
15.2.2.6.2. Product Strategy
15.2.2.6.3. Channel Strategy
15.2.3. Vetoquinol S.A.
15.2.3.1. Overview
15.2.3.2. Product and Application Portfolio
15.2.3.3. Production Footprint
15.2.3.4. Sales Footprint
15.2.3.5. Channel Footprint
15.2.3.6. Strategy
15.2.3.6.1. Marketing Strategy
15.2.3.6.2. Product Strategy
15.2.3.6.3. Channel Strategy
15.2.4. Norbrook Laboratories Limited
15.2.4.1. Overview
15.2.4.2. Product and Application Portfolio
15.2.4.3. Production Footprint
15.2.4.4. Sales Footprint
15.2.4.5. Channel Footprint
15.2.4.6. Strategy
15.2.4.6.1. Marketing Strategy
15.2.4.6.2. Product Strategy
15.2.4.6.3. Channel Strategy
15.2.5. Aratana Therapeutics Inc.
15.2.5.1. Overview
15.2.5.2. Product and Application Portfolio
15.2.5.3. Production Footprint
15.2.5.4. Sales Footprint
15.2.5.5. Channel Footprint
15.2.5.6. Strategy
15.2.5.6.1.1. Marketing Strategy
15.2.5.6.1.2. Product Strategy
15.2.5.6.1.3. Channel Strategy
15.2.6. Boehringer Ingelheim
15.2.6.1. Overview
15.2.6.2. Product and Application Portfolio
15.2.6.3. Production Footprint
15.2.6.4. Sales Footprint
15.2.6.5. Channel Footprint
15.2.6.6. Strategy
15.2.6.6.1. Marketing Strategy
15.2.6.6.2. Product Strategy
15.2.6.6.3. Channel Strategy
15.2.7. Zoetis Inc.
15.2.7.1. Overview
15.2.7.2. Product and Application Portfolio
15.2.7.3. Production Footprint
15.2.7.4. Sales Footprint
15.2.7.5. Channel Footprint
15.2.7.6. Strategy
15.2.7.6.1. Marketing Strategy
15.2.7.6.2. Product Strategy
15.2.7.6.3. Channel Strategy
15.2.8. Bayer AG
15.2.8.1. Overview
15.2.8.2. Product and Application Portfolio
15.2.8.3. Production Footprint
15.2.8.4. Sales Footprint
15.2.8.5. Channel Footprint
15.2.8.6. Strategy
15.2.8.6.1. Marketing Strategy
15.2.8.6.2. Product Strategy
15.2.8.6.3. Channel Strategy
15.2.9. VetStem Biopharma
15.2.9.1. Overview
15.2.9.2. Product and Application Portfolio
15.2.9.3. Production Footprint
15.2.9.4. Sales Footprint
15.2.9.5. Channel Footprint
15.2.9.6. Strategy
15.2.9.6.1. Marketing Strategy
15.2.9.6.2. Product Strategy
15.2.9.6.3. Channel Strategy
15.2.10. Dechra Pharmaceuticals PLC
15.2.10.1. Overview
15.2.10.2. Product and Application Portfolio
15.2.10.3. Production Footprint
15.2.10.4. Sales Footprint
15.2.10.5. Channel Footprint
15.2.10.6. Strategy
15.2.10.6.1. Marketing Strategy
15.2.10.6.2. Product Strategy
15.2.10.6.3. Channel Strategy
16. Global Canine Arthritis Treatment Market Analysis 2013–2017 and Forecast 2018–2028 By Region
16.1. Introduction / Key Findings
16.2. Historical Market Size (US$ Mn) Analysis By Region
16.2.1. North America
16.2.2. Latin America
16.2.3. Europe
16.2.4. Asia Pacific Excluding Japan
16.2.5. Japan
16.2.6. Middle East and Afica
16.3. Market Size (US$ Mn) Forecast By Region, 2018-2028
16.4. Market Attractiveness Analysis By Region
17. Global Canine Arthritis Treatment Market Analysis 2013–2017 and Forecast 2018–2028, By Treatment Type
17.1. Introduction/Key Finding
17.2.Historical Market Size (US$ Mn) Trend Analysis By Treatment Type, 2013-2017
17.2.1. Non-steroidal anti-inflammatory medications (NSAIDs)
17.2.2. Opioids
17.2.3. Stem Cell Therapy
17.2.3.1. Allogeneic Stem Cell
17.2.3.2. Autologous Stem Cell
17.3. Market Size (US$ Mn) Forecast By Treatment Type, 2018-2028
17.4. Market Attractiveness Analysis By Treatment Type
18. Global Canine Arthritis Treatment Market Analysis 2013–2017 and Forecast 2018–2028, By Route of Administration
18.1. Introduction/Key Finding
18.2.Historical Market Size (US$ Mn) Trend Analysis By Route of Administration, 2013-2017
18.2.1. Oral
18.2.2. Injectable
18.3. Market Size (US$ Mn) Forecast By Route of Administration, 2018-2028
18.4. Market Attractiveness Analysis By Route of Administration
19. Global Canine Arthritis Treatment Market Analysis 2013–2017 and Forecast 2018–2028, By End User
19.1.Introduction/Key Finding
19.2.Historical Market Size (US$ Mn) Trend Analysis By End User, 2013-2017
19.2.1. Veterinary Hospitals & Clinics
19.2.2. Retail Pharmacies
19.2.3. Drug Stores
19.2.4. E-commerce
19.3.Market Size (US$ Mn) Forecast By End User, 2018-2028
19.4.Market Attractiveness Analysis By End User
20. Global Canine Arthritis Treatment Market Analysis 2013–2017 and Forecast 2018–2028
20.1.Market Value Share Analysis By All Segment
20.2.Y-o-Y Growth Analysis By All Segment
20.3.Absolute $ Opportunity
21. Assumptions and Acronyms Used
22. Research Methodology
Canine Arthritis Market Reports - List of Tables
Table 01: North America Canine Arthritis Treatment Market size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028, By Treatment Type
Table 02: North America Canine Arthritis Treatment Market size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028, By Route of Administration
Table 03: North America Canine Arthritis Treatment Market size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028, By End User
Table 04: North America Canine Arthritis Treatment Market size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028, By Country
Table 05: Latin America Canine Arthritis Treatment Market size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028, By Treatment Type
Table 06: Latin America Canine Arthritis Treatment Market size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028, By Route of Administration
Table 07: Latin America Canine Arthritis Treatment Market size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028, By End User
Table 08: Latin America Canine Arthritis Treatment Market size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028, By Country
Table 09: Europe Canine Arthritis Treatment Market size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028, By Treatment Type
Table 10: Europe Canine Arthritis Treatment Market size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028, By Route of Administration
Table 11: Europe Canine Arthritis Treatment Market size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028, By End User
Table 12: Europe Canine Arthritis Treatment Market size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028, By Country
Table 13: APEJ Canine Arthritis Treatment Market size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028, By Treatment Type
Table 14: APEJ Canine Arthritis Treatment Market size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028, By Route of Administration
Table 15: APEJ Canine Arthritis Treatment Market size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028, By End User
Table 16: APEJ Canine Arthritis Treatment Market size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028, By Country
Table 17: Japan Canine Arthritis Treatment Market size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028, By Treatment Type
Table 18: Japan Canine Arthritis Treatment Market size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028, By Route of Administration
Table 19: Japan Canine Arthritis Treatment Market size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028, By End User
Table 20: MEA Canine Arthritis Treatment Market size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028, By Treatment Type
Table 21: MEA Canine Arthritis Treatment Market size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028, By Route of Administration
Table 22: MEA Canine Arthritis Treatment Market size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028, By End User
Table 23: MEA Canine Arthritis Treatment Market size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028, By Country
Table 24: Global Canine Arthritis Treatment Market size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028, By Region
Table 25: Global Canine Arthritis Treatment Market size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028, By Treatment Type
Table 26: Global Canine Arthritis Treatment Market size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028, By Route of Administration
Table 27: Global Canine Arthritis Treatment Market size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028, By End User
Canine Arthritis Market Reports - List of Figures
Figure 01: Global Market size (US$ Mn) 2018E, By Treatment Type
Figure 02: North America Canine Arthritis Treatment Market size (US$ Mn) Analysis, 2018 & 2028
Figure 03: Global Canine Arthritis Treatment Market Revenue Opportunity Analysis, By Region 2018-2028
Figure 04: Europe Estimated Breakdown of Pet Industry Expenditure (US$ Bn), By Service 2017
Figure 05: Total U.S. Pet Industry Expenditures (US$ Bn), 2017
Figure 06: Global Healthcare Expenditure in US$ Tn (2013–2020)
Figure 07: Global Canine Arthritis Treatment Market, 2017A
Figure 08:North America Canine Arthritis Treatment Market Value Share, By Route of Administration (2017A)
Figure 09: North America Canine Arthritis Treatment Market Value Share, By Treatment Type (2017A
Figure 10: North America Canine Arthritis Treatment Market Value Share (2017A), By End User
Figure 11: North America Canine Arthritis Treatment Market size (US$ Mn) Analysis, 2013–2017
Figure 12: North America Canine Arthritis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 13: North America NSAIDs Canine Arthritis Treatment Market size (US$ Mn) Analysis, 2013–2017
Figure 14: North America NSAIDs Canine Arthritis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 15: North America Opioids Canine Arthritis Treatment Market size (US$ Mn) Analysis, 2013–2017
Figure 16: North America Opioids Canine Arthritis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 17: North America Stem Cell Therapy Canine Arthritis Treatment Market size (US$ Mn) Analysis, 2013–2017
Figure 18: North America Stem Cell Therapy Canine Arthritis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 19: North America Oral Canine Arthritis Treatment Market size (US$ Mn) Analysis, 2013–2017
Figure 20: North America Oral Canine Arthritis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 21: North America Injectable Canine Arthritis Treatment Market size (US$ Mn) Analysis, 2013–2017
Figure 22: North America Injectable Canine Arthritis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 23: North America Veterinary Hospitals & Clinics Market size (US$ Mn) Analysis, 2013–2017
Figure 24: North America Veterinary Hospitals & Clinics Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 25: North America Retail Pharmacies Market size (US$ Mn) Analysis, 2013–2017
Figure 26: North America Retail Pharmacies Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 27: North America Drug Stores Market size (US$ Mn) Analysis, 2013–2017
Figure 28: North America Drug Stores Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 29: North America E-commerce Market size (US$ Mn) Analysis, 2013–2017
Figure 30: North America E-commerce Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 31: US Market size (US$ Mn) Analysis, 2013–2017
Figure 32: US Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 33: Canada Market size (US$ Mn) Analysis, 2013–2017
Figure 34: Canada Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 35: North America Canine Arthritis Treatment Market Attractiveness Analysis, By Treatment Type
Figure 36: North America Canine Arthritis Treatment Market Attractiveness Analysis, By Route of Administration
Figure 37: North America Canine Arthritis Treatment Market Attractiveness Analysis, By End User
Figure 38: North America Canine Arthritis Treatment Market Attractiveness Analysis, By Country
Figure 39: Latin America Canine Arthritis Treatment Market Value Share, By Route of Administration (2017A)
Figure 40: Latin America Canine Arthritis Treatment Market Value Share, By Treatment Type (2017A)
Figure 41: Latin America Canine Arthritis Treatment Market Value Share (2017A), By End User
Figure 42: Latin America Canine Arthritis Treatment Market size (US$ Mn) Analysis, 2013–2017
Figure 43: Latin America Canine Arthritis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 44: Latin America NSAIDs Canine Arthritis Treatment Market size (US$ Mn) Analysis, 2013–2017
Figure 45: Latin America NSAIDs Canine Arthritis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 46: Latin America Opioids Canine Arthritis Treatment Market size (US$ Mn) Analysis, 2013–2017
Figure 47: Latin America Opioids Canine Arthritis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 48:Latin America Stem Cell Therapy Canine Arthritis Treatment Market size (US$ Mn) Analysis, 2013–2017
Figure 49: Latin America Stem Cell Therapy Canine Arthritis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 50: Latin America Oral Canine Arthritis Treatment Market size (US$ Mn) Analysis, 2013–2017
Figure 51: Latin America Oral Canine Arthritis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 52: Latin America Injectable Canine Arthritis Treatment Market size (US$ Mn) Analysis, 2013–2017
Figure 53: Latin America Injectable Canine Arthritis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 54: Latin America Veterinary Hospitals & Clinics Market size (US$ Mn) Analysis, 2013–2017
Figure 55: Latin America Veterinary Hospitals & Clinics Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 56: Latin America Retail Pharmacies Market size (US$ Mn) Analysis, 2013–2017
Figure 57: Latin America Retail Pharmacies Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 58: Latin America Drug Stores Market size (US$ Mn) Analysis, 2013–2017
Figure 59: Latin America Drug Stores Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 60: Latin America E-commerce Market size (US$ Mn) Analysis, 2013–2017
Figure 61: Latin America E-commerce Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 62: Brazil Market size (US$ Mn) Analysis, 2013–2017
Figure 63: Brazil Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 64: Mexico Market size (US$ Mn) Analysis, 2013–2017
Figure 65: Mexico Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 66: Rest of LA Market size (US$ Mn) Analysis, 2013–2017
Figure 67: Rest of LA Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 68: Latin America Canine Arthritis Treatment Market Attractiveness Analysis, By Treatment Type
Figure 69: Latin America Canine Arthritis Treatment Market Attractiveness Analysis, By Route of Administration
Figure 70: Latin America Canine Arthritis Treatment Market Attractiveness Analysis, By End User
Figure 71: Latin America Canine Arthritis Treatment Market Attractiveness Analysis, By Country
Figure 72: Europe Canine Arthritis Treatment Market Value Share, By Route of Administration (2017A)
Figure 73: Europe Canine Arthritis Treatment Market Value Share, By Treatment Type (2017A)
Figure 74: Europe Canine Arthritis Treatment Market Value Share (2017A), By End User
Figure 75: Europe Canine Arthritis Treatment Market size (US$ Mn) Analysis, 2013–2017
Figure 76: Europe Canine Arthritis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 77: Europe NSAIDs Canine Arthritis Treatment Market size (US$ Mn) Analysis, 2013–2017
Figure 78: Europe NSAIDs Canine Arthritis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 79: Europe Opioids Canine Arthritis Treatment Market size (US$ Mn) Analysis, 2013–2017
Figure 80: Europe Opioids Canine Arthritis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 81: Europe Stem Cell Therapy Canine Arthritis Treatment Market size (US$ Mn) Analysis, 2013–2017
Figure 82: Europe Stem Cell Therapy Canine Arthritis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 83: Europe Oral Canine Arthritis Treatment Market size (US$ Mn) Analysis, 2013–2017
Figure 84: Europe Oral Canine Arthritis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 85: Europe Injectable Canine Arthritis Treatment Market size (US$ Mn) Analysis, 2013–2017
Figure 86: Europe Injectable Canine Arthritis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 87: Europe Veterinary Hospitals & Clinics Market size (US$ Mn) Analysis, 2013–2017
Figure 88: Europe Veterinary Hospitals & Clinics Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 89: Europe Retail Pharmacies Market size (US$ Mn) Analysis, 2013–2017
Figure 90: Europe Retail Pharmacies Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 91: Europe Drug Stores Market size (US$ Mn) Analysis, 2013–2017
Figure 92: Europe Drug Stores Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 93: Europe E-commerce Market size (US$ Mn) Analysis, 2013–2017
Figure 94: Europe E-commerce Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 95: Germany Market size (US$ Mn) Analysis, 2013–2017
Figure 96: Germany Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 97: France Market size (US$ Mn) Analysis, 2013–2017
Figure 98: France Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 99:U.K. Market size (US$ Mn) Analysis, 2013–2017
Figure 100: U.K. Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 101: Italy Market size (US$ Mn) Analysis, 2013–2017
Figure 102: Italy Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 103:Spain Market size (US$ Mn) Analysis, 2013–2017
Figure 104: Spain Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 105: Russia Market size (US$ Mn) Analysis, 2013–2017
Figure 106: Russia Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 107: Rest of Europe Market size (US$ Mn) Analysis, 2013–2017
Figure 108: Rest of Europe Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 109: Europe Canine Arthritis Treatment Market Attractiveness Analysis, By Treatment Type
Figure 110: Europe Canine Arthritis Treatment Market Attractiveness Analysis, By Route of Administration
Figure 111: Europe Canine Arthritis Treatment Market Attractiveness Analysis, By End User
Figure 112: Europe Canine Arthritis Treatment Market Attractiveness Analysis, By Country
Figure 113: APEJ Canine Arthritis Treatment Market Value Share, By Route of Administration (2017A)
Figure 114: APEJ Canine Arthritis Treatment Market Value Share, By Treatment Type (2017A)
Figure 115: APEJ Canine Arthritis Treatment Market Value Share (2017A), By End User
Figure 116: APEJ Canine Arthritis Treatment Market size (US$ Mn) Analysis, 2013–2017
Figure 117: APEJ Canine Arthritis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 118: APEJ NSAIDs Canine Arthritis Treatment Market size (US$ Mn) Analysis, 2013–2017
Figure 119: APEJ NSAIDs Canine Arthritis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 120: APEJ Opioids Canine Arthritis Treatment Market size (US$ Mn) Analysis, 2013–2017
Figure 121: APEJ Opioids Canine Arthritis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 122: APEJ Stem Cell Therapy Canine Arthritis Treatment Market size (US$ Mn) Analysis, 2013–2017
Figure 123: APEJ Stem Cell Therapy Canine Arthritis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 124: APEJ Oral Canine Arthritis Treatment Market size (US$ Mn) Analysis, 2013–2017
Figure 125: APEJ Oral Canine Arthritis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 126: APEJ Injectable Canine Arthritis Treatment Market size (US$ Mn) Analysis, 2013–2017
Figure 127: APEJ Injectable Canine Arthritis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 128: APEJ Veterinary Hospitals & Clinics Market size (US$ Mn) Analysis, 2013–2017
Figure 129: APEJ Veterinary Hospitals & Clinics Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 130: APEJ Retail Pharmacies Market size (US$ Mn) Analysis, 2013–2017
Figure 131: APEJ Retail Pharmacies Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 132: APEJ Drug Stores Market size (US$ Mn) Analysis, 2013–2017
Figure 133: APEJ Drug Stores Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 134: APEJ E-commerce Market size (US$ Mn) Analysis, 2013–2017
Figure 135: APEJ E-commerce Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 136: China Market size (US$ Mn) Analysis, 2013–2017
Figure 137: China Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 138: India Market size (US$ Mn) Analysis, 2013–2017
Figure 139: India Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 140: Australia and New Zealand Market size (US$ Mn) Analysis, 2013–2017
Figure 141: Australia and New Zealand Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 142: ASEAN Market size (US$ Mn) Analysis, 2013–2017
Figure 143: ASEAN Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 144: Rest of APEJ Market size (US$ Mn) Analysis, 2013–2017
Figure 145: Rest of APEJ Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 146: APEJ Canine Arthritis Treatment Market Attractiveness Analysis, By End User
Figure 147: APEJ Canine Arthritis Treatment Market Attractiveness Analysis, By Country
Figure 148: APEJ Canine Arthritis Treatment Market Attractiveness Analysis, By Treatment Type
Figure 149: APEJ Canine Arthritis Treatment Market Attractiveness Analysis, By Route of Administration
Figure 150: Japan Canine Arthritis Treatment Market Value Share, By Route of Administration (2017A)
Figure 151: Japan Canine Arthritis Treatment Market Value Share, By Treatment Type (2017A)
Figure 152: Japan Canine Arthritis Treatment Market Value Share (2017A), By End User
Figure 153: Japan Canine Arthritis Treatment Market size (US$ Mn) Analysis, 2013–2017
Figure 154: Japan Canine Arthritis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 155: Japan NSAIDs Canine Arthritis Treatment Market size (US$ Mn) Analysis, 2013–2017
Figure 156: Japan NSAIDs Canine Arthritis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 157: Japan Opioids Canine Arthritis Treatment Market size (US$ Mn) Analysis, 2013–2017
Figure 158: Japan Opioids Canine Arthritis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 159: Japan Stem Cell Therapy Canine Arthritis Treatment Market size (US$ Mn) Analysis, 2013–2017
Figure 160: Japan Stem Cell Therapy Canine Arthritis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 161: Japan Oral Canine Arthritis Treatment Market size (US$ Mn) Analysis, 2013–2017
Figure 162: Japan Oral Canine Arthritis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 163: Japan Injectable Canine Arthritis Treatment Market size (US$ Mn) Analysis, 2013–2017
Figure 164: Japan Injectable Canine Arthritis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 165: Japan Veterinary Hospitals & Clinics Market size (US$ Mn) Analysis, 2013–2017
Figure 166: Japan Veterinary Hospitals & Clinics Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 167: Japan Retail Pharmacies Market size (US$ Mn) Analysis, 2013–2017
Figure 168: Japan Retail Pharmacies Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 169: Japan Drug Stores Market size (US$ Mn) Analysis, 2013–2017
Figure 170: Japan Drug Stores Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 171: Japan E-commerce Market size (US$ Mn) Analysis, 2013–2017
Figure 172: Japan E-commerce Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 173: Japan Canine Arthritis Treatment Market Attractiveness Analysis, By Treatment Type
Figure 174: Japan Canine Arthritis Treatment Market Attractiveness Analysis, By Route of Administration
Figure 175: Japan Canine Arthritis Treatment Market Attractiveness Analysis, By Treatment Type
Figure 176: Japan Canine Arthritis Treatment Market Attractiveness Analysis, By Route of Administration
Figure 177: MEA Canine Arthritis Treatment Market Value Share, By Route of Administration (2017A)
Figure 178: MEA Canine Arthritis Treatment Market Value Share, By Treatment Type (2017A)
Figure 179: MEA Canine Arthritis Treatment Market Value Share (2017A), By End User
Figure 180: MEA Canine Arthritis Treatment Market size (US$ Mn) Analysis, 2013–2017
Figure 181: MEA Canine Arthritis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 182: MEA NSAIDs Canine Arthritis Treatment Market size (US$ Mn) Analysis, 2013–2017
Figure 183: MEA NSAIDs Canine Arthritis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 184: MEA Opioids Canine Arthritis Treatment Market size (US$ Mn) Analysis, 2013–2017
Figure 185: MEA Opioids Canine Arthritis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 186: MEA Stem Cell Therapy Canine Arthritis Treatment Market size (US$ Mn) Analysis, 2013–2017
Figure 187: MEA Stem Cell Therapy Canine Arthritis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 188: MEA Oral Canine Arthritis Treatment Market size (US$ Mn) Analysis, 2013–2017
Figure 189: MEA Oral Canine Arthritis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 190: MEA Injectable Canine Arthritis Treatment Market size (US$ Mn) Analysis, 2013–2017
Figure 191: MEA Injectable Canine Arthritis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 192: MEA Veterinary Hospitals & Clinics Market size (US$ Mn) Analysis, 2013–2017
Figure 193: MEA Veterinary Hospitals & Clinics Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 194: MEA Retail Pharmacies Market size (US$ Mn) Analysis, 2013–2017
Figure 195: MEA Retail Pharmacies Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 196: MEA Drug Stores Market size (US$ Mn) Analysis, 2013–2017
Figure 197: MEA Drug Stores Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 198: MEA E-commerce Market size (US$ Mn) Analysis, 2013–2017
Figure 199: MEA E-commerce Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 200: GCC Market size (US$ Mn) Analysis, 2013–2017
Figure 201: GCC Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 202: South Africa Market size (US$ Mn) Analysis, 2013–2017
Figure 203: South Africa Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 204: Rest of MEA Market size (US$ Mn) Analysis, 2013–2017
Figure 205: Rest of MEA Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 206: MEA Canine Arthritis Treatment Market Attractiveness Analysis, By End User
Figure 207: MEA Canine Arthritis Treatment Market Attractiveness Analysis, By Country
Figure 208: MEA Canine Arthritis Treatment Market Attractiveness Analysis, By Treatment Type
Figure 209: MEA Canine Arthritis Treatment Market Attractiveness Analysis, By Route of Administration
Figure 210: Global Canine Arthritis Treatment Market Share Analysis (%) By Region, 2018 & 2028
Figure 211: Global Canine Arthritis Treatment Market Y-o-Y Growth (%) By Region, 2018–2028
Figure 212:Global Canine Arthritis Treatment Market Attractiveness Analysis By Region, 2018–2028
Figure 213: Global Canine Arthritis Treatment Market Share Analysis (%) By Treatment Type, 2018 & 2028
Figure 214: Global Canine Arthritis Treatment Market Y-o-Y Growth (%) By Treatment Type, 2018–2028
Figure 215: Global Canine Arthritis Treatment Market Attractiveness Analysis By Treatment Type, 2018–2028
Figure 216: Global Canine Arthritis Treatment Market Share Analysis (%) By Route of Administration, 2018 & 2028
Figure 217: Global Canine Arthritis Treatment Market Y-o-Y Growth (%) By Route of Administration, 2018–2028
Figure 218: Global Canine Arthritis Treatment Market Attractiveness Analysis By Route of Administration, 2018–2028
Figure 219: Global Canine Arthritis Treatment Market Share Analysis (%) By End User, 2018 & 2028
Figure 220: Global Canine Arthritis Treatment Market Y-o-Y Growth (%) By End User, 2018–2028
Figure 221: Global Canine Arthritis Treatment Market Attractiveness Analysis By End User, 2018–2028
Figure 222: Global Canine Arthritis Treatment Market Value Analysis and Forecast, 2017–2028 (US$ Mn)
Figure 223: Global Canine Arthritis Treatment Market Absolute $ Opportunity (US$ Mn), 2017–2028